🇺🇸 Hexavalent vaccine in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Bronchitis — 1 report (12.5%)
2. Inflammatory Marker Increased — 1 report (12.5%)
3. Influenza — 1 report (12.5%)
4. Intraventricular Haemorrhage — 1 report (12.5%)
5. Pyrexia — 1 report (12.5%)
6. Respiratory Syncytial Virus Infection — 1 report (12.5%)
7. Rhinovirus Infection — 1 report (12.5%)
8. Superinfection Bacterial — 1 report (12.5%)

Source database →

Frequently asked questions

Is Hexavalent vaccine approved in United States?

Hexavalent vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Hexavalent vaccine in United States?

International Centre for Diarrhoeal Disease Research, Bangladesh is the originator. The local marketing authorisation holder may differ — check the official source linked above.